3D Cell Cultures
This is a guest post from the BiotechBlog Intern, Fintan Burke. Fintan is a student at the School of Biotechnology […]
This is a guest post from the BiotechBlog Intern, Fintan Burke. Fintan is a student at the School of Biotechnology […]
I am once again honored to be judging the Biotech Humanitarian Award. The Biotech Humanitarian Award is given to an
2012 Biotech Humanitarian Award Nominations Open Read Post »
The Author discusses the recent productivity problems in the pharmaceutical industry, in the context of his 30 year career, and the current responses of the industry driven strongly by disaggregation of the historic R&D model, new fluidites of capi…
New paradigms in drug R&D: A personal perspective Read Post »
This article provides an overview of the impact of raising capital on the equity ownership structure of a biotechnology company. The equity ownership structure as captured in a table of capitalization determines how the fruits of success will be divide…
This article covers the essentials of constructing and delivering a “pitch” of a business opportunity to potential investors or corporate partners. We advocate constructing an effective pitch first and then using that as a guide to prepare your b…
Due diligence, as it applies to venture capital, is actually imprecise. Origins of the term are based in banking case law. Due diligence to the attorney is more of a precise concept. A better term is “homework.” Better indeed, because the burden of…
What Every Biotech Entrepreneur Needs to Know about VC Due Diligence Read Post »
This article focuses on the essentials of building effective, collaborative, team-based organizations. The entrepreneurs and innovators who found and build technology-based organizations comprise out target audience, but most specifically we address th…
For many years the United States has led the world in government support for non-military research and development (R&D), especially support for work that directly relates to health and human development. A focal point for such federal investment…
Partnering With the NIH: Now Part of the “Value Proposition” for Start-ups Read Post »
Before considering the specific regulatory requirements and expectations relating to your product it is informative to understand who regulates and why. Full details at the Journal of Commercial Biotechnology
As surely as the bio-enterprise can benefit from positive media coverage, it cannot thrive in the face of unanswered negative and/or inaccurate media attention. On all counts, the bio-enterprise must be able to strategically engage with the media at ev…
Strategic Engagement of the Science-Business Media Read Post »
Get new actionable insights and updates from BiotechBlog